The Longitudinal Chronic Kidney Disease Study: A Prospective Cohort Study of Predialysis Renal Failure
dc.contributor.author | Perlman, Rachel L. | en_US |
dc.contributor.author | Kiser, Margaret | en_US |
dc.contributor.author | Finkelstein, Fredric | en_US |
dc.contributor.author | Eisele, George | en_US |
dc.contributor.author | Roys, Erik | en_US |
dc.contributor.author | Liu, Lei | en_US |
dc.contributor.author | Burrows-Hudson, Sally | en_US |
dc.contributor.author | Port, Friedrich K. | en_US |
dc.contributor.author | Messana, Joseph M. | en_US |
dc.contributor.author | Bailie, George | en_US |
dc.contributor.author | Rajagopalan, Sanjay | en_US |
dc.contributor.author | Saran, Rajiv | en_US |
dc.date.accessioned | 2010-06-01T21:00:01Z | |
dc.date.available | 2010-06-01T21:00:01Z | |
dc.date.issued | 2003-11 | en_US |
dc.identifier.citation | Perlman, Rachel L.; Kiser, Margaret; Finkelstein, Fredric; Eisele, George; Roys, Erik; Liu, Lei; Burrows-Hudson, Sally; Port, Friedrich; Messana, Joseph M.; Bailie, George; Rajagopalan, Sanjay; Saran, Rajiv (2003). "The Longitudinal Chronic Kidney Disease Study: A Prospective Cohort Study of Predialysis Renal Failure." Seminars in Dialysis 16(6): 418-423. <http://hdl.handle.net/2027.42/74093> | en_US |
dc.identifier.issn | 0894-0959 | en_US |
dc.identifier.issn | 1525-139X | en_US |
dc.identifier.uri | https://hdl.handle.net/2027.42/74093 | |
dc.identifier.uri | http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=14629599&dopt=citation | en_US |
dc.description.abstract | Chronic kidney disease (CKD) is a significant public health problem: every year the number of Americans living with CKD and requiring renal replacement therapy increases. In addition, individuals with CKD have substantially increased morbidity and mortality compared to the general population. The Longitudinal Chronic Kidney Dialysis (LCKD) Study is a multicenter, prospective, observational study of patients with moderate to severe CKD that was designed to better describe the course of the disease and the determinants of patient outcomes. Patients with moderate to severe CKD (glomerular filtration rate [GFR] < 60 ml/min/m 2 ) from four academic nephrology clinics were enrolled between 2000 and 2002. Special cardiac and vascular testing has recently commenced as phase II of this study. Areas that have been or are currently being studied include anemia management, health-related quality of life (HRQOL), medication use, and markers of cardiovascular disease. This article describes the LCKD Study in the context of current knowledge of CKD. | en_US |
dc.format.extent | 124206 bytes | |
dc.format.extent | 3109 bytes | |
dc.format.mimetype | application/pdf | |
dc.format.mimetype | text/plain | |
dc.publisher | Blackwell Science Inc | en_US |
dc.rights | 2003 Blackwell Publishing | en_US |
dc.title | The Longitudinal Chronic Kidney Disease Study: A Prospective Cohort Study of Predialysis Renal Failure | en_US |
dc.type | Article | en_US |
dc.subject.hlbsecondlevel | Internal Medicine and Specialties | en_US |
dc.subject.hlbtoplevel | Health Sciences | en_US |
dc.description.peerreviewed | Peer Reviewed | en_US |
dc.contributor.affiliationum | * Division of Nephrology, Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan | en_US |
dc.contributor.affiliationum | ¶ Department of Biostatistics, Kidney Epidemiology and Cost Center, School of Public Health, University of Michigan, Ann Arbor, Michigan | en_US |
dc.contributor.affiliationum | ** University Renal Research and Education Association, Ann Arbor, Michigan | en_US |
dc.contributor.affiliationum | †† Department of Cardiovascular Medicine, University of Michigan, Ann Arbor, Michigan | en_US |
dc.contributor.affiliationother | † Division of Nephrology, Department of Internal Medicine, University of North Carolina–Chapel Hill, Chapel Hill, North Carolina | en_US |
dc.contributor.affiliationother | † Yale Medical Group, Yale University, New Haven, Connecticut | en_US |
dc.contributor.affiliationother | § Division of Nephrology, Department of Internal Medicine, Albany Medical College, Albany, New York | en_US |
dc.contributor.affiliationother | # Amgen, Inc., Thousand Oaks, California | en_US |
dc.identifier.pmid | 14629599 | en_US |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/74093/1/j.1525-139X.2003.16093.x.pdf | |
dc.identifier.doi | 10.1046/j.1525-139X.2003.16093.x | en_US |
dc.identifier.source | Seminars in Dialysis | en_US |
dc.identifier.citedreference | 1. U.S. Renal Data System: USRDS 2002 Annual Data Report: Atlas of End-Stage Renal Disease in the United States. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2002 | en_US |
dc.identifier.citedreference | Coresh J, Astor BC, Greene T, Eknoyan G, Levey AS: Prevalence of chronic kidney disease and decreased renal function in the adult US population: Third Health and Nutrition Examination Survey. Am J Kidney Dis 41: 1 – 12, 2003 | en_US |
dc.identifier.citedreference | 3. The ACE Inhibitors in Diabetic Nephropathy Trial Group: Should all patients with type I diabetes mellitus and microalbuminuria receive angiotensin-converting enzyme inhibitors? Ann Intern Med 134: 370 – 379, 2001 | en_US |
dc.identifier.citedreference | Kshirsagar AV, Joy MS, Hogan SL, Falk RJ, Colindres RE: Effect of ACE inhibitors in diabetic and nondiabetic chronic renal disease: a systematic review of randomized placebo-controlled trials. Am J Kidney Dis 35: 695 – 707, 2000 | en_US |
dc.identifier.citedreference | Jafar TH, Schmid CH, Landa M, Giatras I, Toto R, Remuzzi G, Maschio G, Brenner BM, Kamper A, Zucchelli P, Becker G, Himmelmann A, Bannister K, Landais P, Shahinfar S, de Jong PE, de Zeeuw D, Lau J, Levey AS: Angiotensin-converting enzyme inhibitors and progression of nondiabetic renal disease. Ann Intern Med 135: 73 – 87, 2001 | en_US |
dc.identifier.citedreference | Pereira BJ: Optimization of pre-ESRD care: the key to improved dialysis outcomes. Kidney Int 57: 351 – 365, 2000 | en_US |
dc.identifier.citedreference | Stack AG: Impact of timing of nephrology referral and pre-ESRD care on mortality risk among new ESRD patients in the United States. Am J Kidney Dis 41: 310 – 318, 2003 | en_US |
dc.identifier.citedreference | Kinchen KS, Sadler J, Fink N: The timing of specialist evaluation in chronic kidney disease and mortality. Ann Intern Med 137: 479 – 486, 2002 | en_US |
dc.identifier.citedreference | Avorn J, Bohn RL, Levy E, Levin R, Owen WF, Winkelmayer WC, Glynn RJ: Nephrologist care and mortality in patients with chronic renal insufficiency. Arch Intern Med 162: 2002 – 2006, 2002 | en_US |
dc.identifier.citedreference | 10. National Kidney Foundation: Executive summary. In: K/DOQI Clinical Practice Guidelines for Chronic Kidney Disease. New York: National Kidney Foundation, 2002 | en_US |
dc.identifier.citedreference | 11. European best practice guidelines in nephrology. Nephrol Dial Transplant 14 ( suppl 5 ): 1 – 50, 1999 | en_US |
dc.identifier.citedreference | Rao M, Kausz AT, Mitchell D, Ratican SH, Lin F, Burrows-Hudson S, Port F, Pereira BJ: The study of treatment for renal insufficiency: data and evaluation (STRIDE), a national registry of chronic kidney disease. Semin Dial 15: 366 – 369, 2002 | en_US |
dc.identifier.citedreference | Wright TJ, Kusek JW, Toto RD, Lee JY, Agodoa LY, Kirk KA, Randall OS, Glassock R: Design and baseline characteristics of participants in the African American Study of Kidney Disease and Hypertension (AASK) pilot study. Control Clin Trials 17 ( 4 suppl ): S3 – S16, 1996 | en_US |
dc.identifier.citedreference | Jager KJ, Merkus MP, Boeschoten EW, Dekker FW, Stevens P, Krediet RT, NECOSAD Study Group: Dialysis in the Netherlands: the clinical condition of new patients put into a European perspective. Nephrol Dial Transplant 14: 2438 – 2444, 1999 | en_US |
dc.identifier.citedreference | Xue JL, St. Peter WL, Ebben JP, Everson SE, Collins AJ: Anemia treatment in the pre-ESRD period and associated mortality in elderly patients. Am J Kidney Dis 40: 1153 – 1161, 2002 | en_US |
dc.identifier.citedreference | Fink JC, Blahut SA, Reddy M, Light PD: Use of erythropoietin before the initiation of dialysis and its impact on mortality. Am J Kidney Dis 37: 348 – 355, 2001 | en_US |
dc.identifier.citedreference | Korevaar JC, Merkus MP, Jansen MA, Dekker FW, Boeschoten EW, Krediet RT, NECOSAD Study Group: Validation of the KDQOL-SF TM: a dialysis-targeted health measure. Qual Life Res 11: 437 – 447, 2002 | en_US |
dc.identifier.citedreference | Kusek JW, Greene P, Wang SR, Beck G, West D, Jamerson K, Agodoa LY, Faulkner M: Level B for the African American Study of Kidney Disease and Hypertension Trial Study Group. Cross-sectional study of health related quality of life in African Americans with chronic renal insufficiency: the African American Study of Kidney Disease and Hypertension trial. Am J Kidney Dis 39: 513 – 524, 2002 | en_US |
dc.identifier.citedreference | Ware J, Snow KK, Kosinski M, Gandek B: SF-36 health survey: manual & interpretation guide. Boston: Health Institute, 1993 | en_US |
dc.identifier.citedreference | Ware J, Kosinski M, Keller SD: SF-36 physical and mental health summary scales: a user's manual. Boston: Health Institute, 1994 | en_US |
dc.identifier.citedreference | Lopes AA, Bragg-Gresham JL, Satayathum S, McCullough K, Pifer T, Goodkin DA, Mapes DL, Young EW, Wolfe RA, Held PJ, Port FK, Worldwide DOPPS Committee: Health-related quality of life and associated outcomes among hemodialysis patients of different ethnicities in the United States: the Dialysis Outcomes and Practice Patterns Study (DOPPS). Am J Kidney Dis 41: 605 – 615, 2003 | en_US |
dc.identifier.citedreference | Walters BA, Hays RD, Spritzer KL, Fridman M, Carter WB: Health-related quality of life, depressive symptoms, anemia and malnutrition at hemodialysis initiation. Am J Kidney Dis 40: 1185 – 1194, 2002 | en_US |
dc.identifier.citedreference | Korevaar JC, Jansen MA, Merkus MP, Dekker FW, Boeschoten EW, Krediet RT: Quality of life in predialysis end-stage renal disease patients at the initiation of dialysis therapy. The NECOSAD Study Group. Perit Dial Int 20: 69 – 75, 2000 | en_US |
dc.identifier.citedreference | Levey AS, Beto JA, Coronado BE, Eknoyan G, Foley RN, Kasiske BL, Klag MJ, Mailloux LU, Manske CL, Meyer KB, Parfrey PS, Pfeffer MA, Wenger NK, Wilson PW, Wright JT: Controlling the epidemic of cardiovascular disease in chronic renal disease: What do we know? What do we need to learn? Where do we go from here? Am J Kidney Dis 32: 853 – 906, 1998 | en_US |
dc.identifier.citedreference | Foley RN, Parfrey PS, Sarnak MJ: Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis 32 ( 5 suppl 3 ): S112 – S119, 1998 | en_US |
dc.identifier.citedreference | Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D: A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 130: 461 – 470, 1999 | en_US |
dc.identifier.citedreference | Patel UD, Wright G, Roys EC, Finkelstein F, Kiser M, Eisele G, Burrows-Hudson S, Port FK, Saran R: Anemia management among patients with chronic kidney disease. J Am Soc Nephrol 13: 761A, 2002 | en_US |
dc.identifier.citedreference | Bailie G, Roys EC, Eisele G, Kiser M, Finkelstein F, Wolfe RA, Mason N, Port FK, Burrows-Hudson S, Saran R: Medication use in chronic kidney disease (CKD) patients: analysis of the multicenter longitudinal CKD study. Presented at the National Kidney Foundation Clinical Meetings, Am J Kidney Dis 41: A7, 2003 | en_US |
dc.identifier.citedreference | Saran R, Wolfe RA, Roys EC, Wright G, Kiser M, Eisele G, Finkelstein F, Burrows-Hudson S, Port FK: Predictors of quality of life (Qol) in chronic kidney disease (CKD): cross-sectional analysis in the multicenter longitudinal CKD study. J Am Soc Nephrol 13: 520A, 2002 | en_US |
dc.identifier.citedreference | Perlman R, Roys EC, Finkelstein F, Kiser M, Eisele G, Burrows-Hudson S, Messana J, Port FK, Wolfe RA, Saran R: Quality of life (QOL) in patients with chronic kidney disease (CKD): a longitudinal study. Presented at the National Kidney Foundation Clinical Meetings, Am J Kidney Dis 41: A8, 2003 | en_US |
dc.identifier.citedreference | Feldman HI, Appel LJ, Chertow GM, Cifelli D, Cizman B, Daugirdas J, Fink JC, Franklin-Becker ED, Go AS, Hamm LL, He J, Hostetter T, Hsu CY, Jamerson K, Joffe M, Kusek JW, Landis JR, Lash JP, Miller ER, Mohler ER 3rd, Muntner P, Ojo AO, Rahman M, Townsend RR, Wright JT; Chronic Renal Insufficiency Cohort (CRIC) Study Investigators. The Chronic Renal Insufficiency Cohort (CRIC) Study: Design and Methods. J Am Soc Nephrol 14(7 Suppl 2): S148 – 153, 2003 | en_US |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.